Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, Non-Hodgkin × Palonosetron × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 13 Nausea 11 Neoplasms 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Multiple Myeloma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Radiation Injuries 1 Pancreatic Neoplasms 1 Pain 1 Neoplasms, Germ Cell and Embryonal 1 Nausea With Vomiting Chemotherapy-Induced 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Glioma 1 Gallbladder Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Brain Neoplasms 1 Bile Duct Neoplasms 1 Appendiceal Neoplasms 1 Anus Neoplasms 1

Interventions

Cyclophosphamide 152 Rituximab 146 Etoposide 84 fludarabine phosphate 72 Peripheral Blood Stem Cell Transplantation 68 Mycophenolic Acid 62 Busulfan 61 Filgrastim 59 Melphalan 58 Tacrolimus 53 Whole-Body Irradiation 50 Cytarabine 46 fludarabine 43 Radiotherapy 43 Methotrexate 41 Granulocyte Colony-Stimulating Factor 41 Cyclosporine 40 Antilymphocyte Serum 35 Vincristine 34 Carmustine 33 Doxorubicin 28 Prednisone 26 Thiotepa 24 Bendamustine Hydrochloride 23 Methylprednisolone 22 Ifosfamide 22 thymoglobulin 21 Dexamethasone 21 sargramostim 20 plerixafor 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01018758 2009-11-25

NHLPal

Gruppo Italiano Studio Linfomi

Phase 2 Completed

Lymphoma, Non-Hodgkin, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡